Bioanalytical Testing Services Market Analysis

Global Bioanalytical Testing Services Market Segmentation

The global bioanalytical testing services market is segmented and analyzed for demand and supply by application into cardiology, gastroenterology, neurology, oncology, and others. Out of these, the cardiology segment is estimated to attain the largest share of the market over the forecast period. The growth of the segment can be accounted to the rising cases of cardiovascular diseases owing to unhealthy life choices, lack of exercise, and smoking habits. For instance, in 2020, approximately 600,000 people lost their lives in the United States as a result of cardiovascular disease.

Additionally, by molecule type, the market is segmented into small molecules and large molecules. Out of these, the small molecules segment has the largest market share in 2022, owing to its crucial role in creating generic versions of branded medications, the small molecule testing services sub-segment is predicted to experience growth. The effectiveness of simulating generic medication release profiles with those of branded drugs has been demonstrated through bioanalytical testing, which has contributed to the segment's expansion.

Our in-depth analysis of the global bioanalytical testing services market includes the following segments: